Penumbra, Inc. (PEN)
323.10
+1.42
(+0.44%)
USD |
NYSE |
Aug 31, 16:00
Penumbra Total Long Term Debt (Quarterly) : 198.31M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 198.31M |
| March 31, 2026 | 202.03M |
| December 31, 2025 | 205.86M |
| September 30, 2025 | 203.96M |
| June 30, 2025 | 207.67M |
| March 31, 2025 | 208.14M |
| December 31, 2024 | 211.17M |
| September 30, 2024 | 214.62M |
| June 30, 2024 | 217.04M |
| March 31, 2024 | 219.92M |
| December 31, 2023 | 223.14M |
| September 30, 2023 | 217.97M |
| June 30, 2023 | 220.56M |
| March 31, 2023 | 223.22M |
| December 31, 2022 | 225.74M |
| September 30, 2022 | 208.10M |
| June 30, 2022 | 210.62M |
| March 31, 2022 | 210.33M |
| December 31, 2021 | 165.28M |
| September 30, 2021 | 166.57M |
| June 30, 2021 | 122.62M |
| March 31, 2021 | 71.96M |
| December 31, 2020 | 72.58M |
| September 30, 2020 | 73.72M |
| Date | Value |
|---|---|
| June 30, 2020 | 73.14M |
| March 31, 2020 | 75.36M |
| December 31, 2019 | 78.16M |
| September 30, 2019 | 45.40M |
| June 30, 2019 | 46.15M |
| March 31, 2019 | 46.07M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Boston Scientific Corp. | 12.62B |
| Globus Medical, Inc. | 97.53M |
| Teleflex, Inc. | 2.873B |
| Abbott Laboratories | 32.61B |
| AngioDynamics, Inc. | 9.66M |